Alcohol DrinkingNCT05675332
Effects of Stereotype Threat on Impulsivity and Its Relation to Alcohol Use in African Americans: An fMRI Study
A study testing Task-based behavioral intervention in people with Alcohol Drinking, run by Icahn School of Medicine at Mount Sinai at 1 site in United States.
Trial summary
The purpose of this study is to investigate the behavioral and neural correlates of stress exposure. Results from this study will enrich the understanding of how sociocultural, behavioral, and neural factors combine to influence alcohol use. Read more about this study
- Who is it for?
- Ages 21 to 35 yearsHealthy volunteers can take part
- Conditions the study is for
- Alcohol Drinking
- What is being tested?
- Task-based behavioral intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 280 participants
- Where
- 1 siteUnited States
- Study dates
- 9 Dec 2022to 31 Jan 2027
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 to 35 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Between 21 and 35 years of age (inclusive);
- Fluent in English;
- Right-handed
Who cannot join
- Younger than 21 years of age;
- Left-handed
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Icahn School of Medicine at Mount Sinai
New York, New York, 10029
Uraina Clark, PhD
About this study
The purpose of this study is to investigate the behavioral and neural correlates of stress exposure. Results from this study will enrich the understanding of how sociocultural, behavioral, and neural factors combine to influence alcohol use.
- Conditions
- Alcohol Drinking
- Being tested
- Task-based behavioral intervention
- Medical subject headings
- Alcohol Drinking
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Task-based behavioral interventionBehavioural
Brief behavioral intervention is absent of stressors.
Task-based behavioral interventionBehavioural
Brief behavioral intervention involves interacting with common everyday types of stress.
| Study group | Role | What they receive |
|---|---|---|
| no stress exposure | Placebo comparator | no threat stress Receives: Behavioral: Task-based behavioral intervention |
| stress exposure | Active comparator | exposure to stress threat Receives: Behavioral: Task-based behavioral intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Blood oxygen-level dependent (BOLD) signal
Blood oxygen-level dependent (BOLD) signal in brain regions of interest (ROI) measured using fMRI
Measured: Baseline
Resting-state functional connectivity in brain regions
Resting-state functional connectivity - brain activity measured using fMRI
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Jan 2023
- Study start9 Dec 2022
- Primary completion31 Jan 2027 (estimated)
- Study completion31 Jan 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Alcohol DrinkingStudies of the same condition, open and under way.
- More trials run by Icahn School of Medicine at Mount SinaiThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 280 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Responsible party
- Principal investigator, Uraina S Clark, Icahn School of Medicine at Mount Sinai
- Investigators
- Uraina Clark, PhD, Principal investigator, Icahn School of Medicine at Mount Sinai
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05675332
- Sponsor's protocol ID
- GCO 19-0250
- Other IDs
- R01AA028023
- Status last verified
- Jun 2026
- First submitted
- 22 Dec 2022
- Last updated
- 25 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: There is no plan to share IPD